- Home
- CLFD vs INBX Comparison
CLFD vs INBX Comparison
Compare CLFD & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLFD
- INBX
- Stock Information
- Founded
- CLFD 1979
- INBX 2010
- Country
- CLFD United States
- INBX United States
- Employees
- CLFD N/A
- INBX N/A
- Industry
- CLFD Telecommunications Equipment
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- CLFD Utilities
- INBX Health Care
- Exchange
- CLFD Nasdaq
- INBX Nasdaq
- Market Cap
- CLFD 494.4M
- INBX 430.2M
- IPO Year
- CLFD N/A
- INBX 2020
- Fundamental
- Price
- CLFD $34.76
- INBX $81.44
- Analyst Decision
- CLFD Strong Buy
- INBX Hold
- Analyst Count
- CLFD 1
- INBX 2
- Target Price
- CLFD $50.00
- INBX N/A
- AVG Volume (30 Days)
- CLFD 81.6K
- INBX 698.6K
- Earning Date
- CLFD 11-06-2025
- INBX 11-14-2025
- Dividend Yield
- CLFD N/A
- INBX N/A
- EPS Growth
- CLFD N/A
- INBX N/A
- EPS
- CLFD 0.01
- INBX N/A
- Revenue
- CLFD $179,319,000.00
- INBX $1,400,000.00
- Revenue This Year
- CLFD $11.41
- INBX $563.00
- Revenue Next Year
- CLFD $13.55
- INBX $230.77
- P/E Ratio
- CLFD $2,424.64
- INBX N/A
- Revenue Growth
- CLFD 5.72
- INBX N/A
- 52 Week Low
- CLFD $23.78
- INBX $10.81
- 52 Week High
- CLFD $46.76
- INBX $83.95
- Technical
- Relative Strength Index (RSI)
- CLFD 45.62
- INBX 85.15
- Support Level
- CLFD $34.21
- INBX $28.16
- Resistance Level
- CLFD $37.00
- INBX $83.95
- Average True Range (ATR)
- CLFD 1.17
- INBX 6.46
- MACD
- CLFD -0.10
- INBX 4.55
- Stochastic Oscillator
- CLFD 15.94
- INBX 95.50
About CLFD Clearfield Inc.
Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a various products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has international presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.